NO20016341D0 - Inhibitors for the integrin <alfa> v <beta> 6 - Google Patents

Inhibitors for the integrin <alfa> v <beta> 6

Info

Publication number: NO20016341D0
Authority: NO; Norway
Prior art keywords: alfa; integrin; inhibitors; beta
Prior art date: 1999-06-26

Application number

NO20016341A

Other languages

Norwegian (no)

Other versions

NO20016341L (en

Inventor

Alfred Jonczyk

Beate Diefenbach

Ulrich Groth

Gunther Zischinsky

Original Assignee

Merck Patent Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-06-26

Filing date

2001-12-21

Publication date

2001-12-21

2001-12-21 Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh

2001-12-21 Publication of NO20016341D0 publication Critical patent/NO20016341D0/en

2002-02-25 Publication of NO20016341L publication Critical patent/NO20016341L/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/02—Linear peptides containing at least one abnormal peptide link
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Physical Education & Sports Medicine (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Communicable Diseases (AREA)
Hematology (AREA)
Neurology (AREA)
Pain & Pain Management (AREA)
Pulmonology (AREA)
Oncology (AREA)
Diabetes (AREA)
Dermatology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

NO20016341A 1999-06-26 2001-12-21 Inhibitors for the integrin <alfa> v <beta> 6 NO20016341L (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE19929410A DE19929410A1 (en)	1999-06-26	1999-06-26	New octapepide compounds as alpha v beta 6 integrin inhibitors useful for treating and diagnosing heart disease, tumors, osteoporosis, fibrosis, inflammation, infection and psoriasis
PCT/EP2000/005404 WO2001000660A1 (en)	1999-06-26	2000-06-13	INHIBITORS OF THE INTEGRIN αvβ¿6?

Publications (2)

Publication Number	Publication Date
NO20016341D0 true NO20016341D0 (en)	2001-12-21
NO20016341L NO20016341L (en)	2002-02-25

Family

ID=7912712

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20016341A NO20016341L (en)	1999-06-26	2001-12-21	Inhibitors for the integrin <alfa> v <beta> 6

Country Status (17)

Country	Link
EP (1)	EP1189930A1 (en)
JP (1)	JP2003503422A (en)
KR (1)	KR20020015704A (en)
CN (1)	CN1358195A (en)
AR (1)	AR024472A1 (en)
AU (1)	AU771099B2 (en)
BR (1)	BR0011954A (en)
CA (1)	CA2377224A1 (en)
CZ (1)	CZ20014484A3 (en)
DE (1)	DE19929410A1 (en)
HU (1)	HUP0201729A3 (en)
MX (1)	MXPA01013247A (en)
NO (1)	NO20016341L (en)
PL (1)	PL352374A1 (en)
SK (1)	SK18722001A3 (en)
WO (1)	WO2001000660A1 (en)
ZA (1)	ZA200200673B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6972296B2 (en)	1999-05-07	2005-12-06	Encysive Pharmaceuticals Inc.	Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
AU2004208865B2 (en) *	2003-02-06	2010-06-17	Merck Patent Gmbh	Peptidic sulfonamides
GB0520068D0 (en) *	2005-10-03	2005-11-09	Cancer Res Technology	av peptide ligand
WO2008112004A2 (en)	2006-08-03	2008-09-18	Astrazeneca Ab	ANTIBODIES DIRECTED TO αVβ6 AND USES THEREOF
EA201991102A1 (en) *	2016-11-01	2019-09-30	Эрроухед Фармасьютикалс, Инк.	ALPHA-V BETA-6 INTEGRINE LIGANDS AND OPTIONS FOR THEIR APPLICATION
AU2018359515B2 (en)	2017-11-01	2024-09-19	Arrowhead Pharmaceuticals, Inc.	Integrin ligands and uses thereof
PH12023552779A1 (en)	2021-04-08	2024-04-15	Arrowhead Pharmaceuticals Inc	Rnai agents for inhibiting expression of receptor for advanced glycation end-products, compositions thereof, and methods of use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2103139A1 (en) *	1991-05-14	1992-11-15	George A. Heavner	Peptide inhibitors of inflammation
DE69840113D1 (en) *	1997-08-08	2008-11-20	Univ California	Treatment of liver fibrosis with anti-alpha V beta 6 integrin antibodies
BR9916323A (en) *	1998-12-19	2001-10-30	Merck Patent Gmbh	Integrin inhibitors alfavbeta6

1999
- 1999-06-26 DE DE19929410A patent/DE19929410A1/en not_active Withdrawn
2000
- 2000-06-13 WO PCT/EP2000/005404 patent/WO2001000660A1/en not_active Ceased
- 2000-06-13 JP JP2001507066A patent/JP2003503422A/en active Pending
- 2000-06-13 CN CN00809493A patent/CN1358195A/en active Pending
- 2000-06-13 CA CA002377224A patent/CA2377224A1/en not_active Abandoned
- 2000-06-13 HU HU0201729A patent/HUP0201729A3/en unknown
- 2000-06-13 SK SK1872-2001A patent/SK18722001A3/en unknown
- 2000-06-13 MX MXPA01013247A patent/MXPA01013247A/en unknown
- 2000-06-13 KR KR1020017016580A patent/KR20020015704A/en not_active Withdrawn
- 2000-06-13 AU AU62630/00A patent/AU771099B2/en not_active Ceased
- 2000-06-13 BR BR0011954-7A patent/BR0011954A/en not_active IP Right Cessation
- 2000-06-13 CZ CZ20014484A patent/CZ20014484A3/en unknown
- 2000-06-13 EP EP00949177A patent/EP1189930A1/en not_active Withdrawn
- 2000-06-13 PL PL00352374A patent/PL352374A1/en unknown
- 2000-06-23 AR ARP000103177A patent/AR024472A1/en not_active Application Discontinuation
2001
- 2001-12-21 NO NO20016341A patent/NO20016341L/en not_active Application Discontinuation
2002
- 2002-01-24 ZA ZA200200673A patent/ZA200200673B/en unknown

Also Published As

Publication number	Publication date
MXPA01013247A (en)	2002-07-02
SK18722001A3 (en)	2002-05-09
CN1358195A (en)	2002-07-10
KR20020015704A (en)	2002-02-28
BR0011954A (en)	2002-05-07
AR024472A1 (en)	2002-10-02
ZA200200673B (en)	2003-04-24
DE19929410A1 (en)	2000-12-28
NO20016341L (en)	2002-02-25
CZ20014484A3 (en)	2002-04-17
CA2377224A1 (en)	2001-01-04
EP1189930A1 (en)	2002-03-27
HUP0201729A2 (en)	2002-08-28
AU6263000A (en)	2001-01-31
HUP0201729A3 (en)	2005-01-28
AU771099B2 (en)	2004-03-11
JP2003503422A (en)	2003-01-28
PL352374A1 (en)	2003-08-25
WO2001000660A1 (en)	2001-01-04

Publication	Publication Date	Title
NO20006268D0 (en)	2000-12-11	<Beta> karbolinforbindelser
EE04517B1 (en)	2005-08-15	Double container
DE69836425D1 (en)	2006-12-28	container
DE69911627D1 (en)	2003-10-30	ISSUE CONTAINER
EP1147107A4 (en)	2002-05-22	ANGIOGENESIS INHIBITORS
DE59911165D1 (en)	2005-01-05	Lyophilisier container
IT245060Y1 (en)	2002-03-19	CONTAINER FOR THE TRANSPORT OF DOMESTIC ANIMALS
DK1063178T3 (en)	2004-12-06	Container connection arrangement
DE69907015D1 (en)	2003-05-22	ISSUE CONTAINER
ATA24499A (en)	2002-11-15	CONTAINER
ID28483A (en)	2001-05-31	2- (3,5-BIS-TRIFLUOROMETYL-PHENIL) -METIL-N- (6-MORFOLIN-4-IL-4-0-TOLYL-PYRIDIN-3-IL) -ISOBUTIRAMIDA
NO20014010L (en)	2001-10-18	<Beta> -alaninderivater
NO20013013L (en)	2001-06-18	<Alpha> v <beta> 6-integrin
IS6191A (en)	2001-12-05	container
DE69928440D1 (en)	2005-12-22	ISSUE CONTAINER
NO20022852L (en)	2002-08-15	Containers
NO20016341D0 (en)	2001-12-21	Inhibitors for the integrin <alfa> v <beta> 6
FI980908A0 (en)	1998-04-24	The reel
DE60023871D1 (en)	2005-12-15	BIN
EP1192168A4 (en)	2003-04-16	GALECTINE 11
FI982378A0 (en)	1998-11-03	Arrangement for the study of the object
NO20020886D0 (en)	2002-02-22	Novel integrin <alfa> v <beta> 3 inhibitors
NO995130D0 (en)	1999-10-21	Liquid manure
EP1082152A4 (en)	2002-02-06	PRE-FILLER CONTAINER
NO20030925D0 (en)	2003-02-27	Gem-substituted alpha V beta 3 integrin antagonists

Legal Events

Date	Code	Title	Description
2005-04-25	FC2A	Withdrawal, rejection or dismissal of laid open patent application